NMN and NR are both NAD+ precursors that support cellular energy production. NR has a larger body of published human trials; NMN sits one step closer to NAD+ in the biosynthesis pathway and appears to have a distinct muscle-uptake route. Both help maintain NAD+ levels already within a normal range.
Why Your Cells Run on NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of your body. Without it, mitochondria cannot produce ATP, the energy currency behind every heartbeat, muscle contraction, and thought. NAD+ also activates a family of proteins called sirtuins, which help maintain healthy gene expression and support cellular maintenance processes.
Here is the part that matters for supplementation: NAD+ levels fall substantially with age. Research across multiple human tissues suggests roughly a 50% decline between our 20s and mid-60s. That is a biological pattern, not a pathology. Supplementing with NAD+ precursors is one approach people use to help maintain levels already within a normal range, supporting the energy-production machinery their cells already have.
NMN and NR are the two most studied precursors. Both convert into NAD+ inside cells. But the path each takes to get there differs, and that difference has real implications for how you choose between them.
NMN and NR: Same Family, Different Molecules
Both molecules belong to the vitamin B3 family. NR (nicotinamide riboside) is one enzymatic step away from NAD+ in the biosynthesis chain. NMN (nicotinamide mononucleotide) is one step closer still, sitting directly adjacent to NAD+ in that chain.
Structurally, NMN is NR with a phosphate group attached. That single addition changes things. The molecule is slightly larger, and for years researchers assumed this meant NMN had to be dephosphorylated back into NR before cells could absorb it. The story got more complicated in 2019.
A transporter protein called Slc12a8 was identified in mouse intestinal cells. It appears to shuttle NMN directly into cells without converting it first. Whether the same mechanism operates robustly in human tissue is still under investigation, but it opens the door to a genuinely distinct absorption route rather than just a longer detour to the same destination.
The Absorption Pathway Debate
NR's absorption path is well-mapped. After ingestion, NR enters cells via nucleoside transporters, gets phosphorylated by NRK1 or NRK2 enzymes into NMN, then converts to NAD+. Human pharmacokinetic data confirm this reliably. A 2016 study published in Nature Communications showed NR is orally bioavailable in healthy humans and raises blood NAD+ within hours of a single dose.
NMN's picture is messier but evolving. Early assumptions held that NMN could not cross the intestinal wall intact and had to be broken down to NR first. The Slc12a8 transporter discovery challenged that view. Some researchers now argue NMN can reach target tissues more directly, particularly skeletal muscle. Whether this translates to meaningfully different real-world outcomes is still being worked out.
Practically speaking: both precursors raise circulating NAD+. The interesting open question is whether NMN travels by a different route that favors specific tissue compartments. The data is suggestive, not settled. That distinction matters when you are deciding which one to try first.
What the Human Research Actually Shows
Clinical trials are where supplementation decisions should be grounded. Not mouse data. Not cell dishes. Here is what human studies have measured so far.
NR (selected human trials):
- Trammell et al. (2016): 1,000 mg per day for six weeks raised whole blood NAD+ by roughly 40-50% versus placebo in healthy adults.
- Martens et al. (2018): 1,000 mg per day for six weeks supported a healthy blood pressure response already within a normal range in older adults.
- Multiple studies have shown NR supports mitochondrial function markers already within a normal range in aging populations.
NMN (selected human trials):
- Irie et al. (2020): 250 mg per day for 10 weeks in older women showed improvements in muscle function measurements and metabolic markers already within a normal range.
- Yoshino et al. (2021): 250 mg per day in postmenopausal women demonstrated measurable skeletal muscle NAD+ uptake, a tissue compartment where prior NR studies had not consistently shown the same signal.
NR has more published human trials right now, largely because industry investment came earlier. NMN's clinical evidence base is catching up quickly. Neither has a knockout win over the other, and honest researchers on both sides will tell you so.
Which One Fits Your Goals
Customers often ask us: should I take NMN or NR? The answer depends on what you are optimizing for.
NR may be a better starting point if:
- You want the larger body of published human data behind your choice.
- You are new to NAD+ precursors and want a well-characterized entry point.
- Budget matters. NR is generally less expensive per gram at equivalent doses.
NMN may suit you better if:
- You are interested in the potential direct muscle-uptake pathway that more recent research supports.
- You want to explore the nicotinamide mononucleotide supplement at the 250-500 mg doses most commonly used in published human trials.
- You are combining with resveratrol or other compounds that have been more frequently studied alongside NMN specifically.
One tolerability note worth flagging: a small percentage of people report mild nausea with NR at higher doses. Published NMN trials up to 1,200 mg per day have reported no serious adverse events, and tolerability across the literature looks clean.
Dosing, Forms, and What to Look For
Both supplements come in capsules, powder, and sublingual forms. A few things worth knowing before you buy.
Dose ranges from human trials: Most NR studies used 500-1,000 mg per day. NMN trials most commonly used 250-600 mg per day, with some going higher. No established optimal dose exists for either. Starting on the lower end and reassessing after four to six weeks is a reasonable approach.
Stability matters more for NMN. It degrades faster than NR when exposed to heat, moisture, or light. Look for opaque, moisture-sealed packaging. Some manufacturers use cold-chain handling during shipping; worth checking if you live somewhere warm.
A note on sublingual forms. Some brands claim sublingual NMN absorbs faster by bypassing first-pass gut metabolism. The head-to-head human data comparing sublingual versus capsule forms is thin right now. Capsules have the most clinical trial backing by a clear margin.
Third-party testing is non-negotiable. The NMN market has had purity variation issues. Look for a certificate of analysis from an independent lab confirming identity, potency, and absence of heavy metals. In our formula, we use pharmaceutical-grade beta-NMN at 500 mg per capsule, tested for purity before it ships.
Making Your Choice
Here is the straight answer: NR has more human trials behind it. NMN sits closer to NAD+ in the synthesis chain and has a growing clinical argument for potentially stronger uptake in skeletal muscle. Both help maintain NAD+ levels already within a normal range. Both are safe at studied doses.
Neither is a substitute for the basics. NAD+ precursors work best alongside consistent movement, adequate sleep, and eating in a way that supports your energy systems rather than depletes them. The supplement fills a real gap; it does not replace the foundation underneath it.
If you are new to NAD+ support, pick one. Run it for 60 to 90 days. Pay attention to how your energy and recovery feel. That personal signal is something no published trial can hand you, and it is the most useful data point you will get.
Frequently asked questions
Can I take NMN and NR at the same time?
There is no known safety concern with taking both. That said, combining them makes it difficult to know which one is producing any response you notice. Most people start with one, give it 60 to 90 days, and adjust from there based on how they feel.
How long before I notice a difference with NMN?
Human trials typically run four to twelve weeks. Some people report subjective changes in energy and recovery within two to four weeks, but measurable NAD+ changes take longer to plateau. Give any NAD+ precursor at least six weeks before drawing conclusions.
Is NMN the same as niacin (vitamin B3)?
Related, but not the same. Niacin converts to NAD+ through a longer pathway. NMN is further along that chain, making the conversion more direct. Niacin at higher doses also causes a skin flush reaction that NMN and NR do not produce, which is a practical difference many people care about.
Does NMN need to be refrigerated?
Not always, but storage conditions matter more for NMN than NR. NMN is more sensitive to heat and moisture. Keeping it in a cool, dark place helps maintain potency over time. Some products specify refrigeration after opening; follow the label guidance on yours.
What dose of NMN do published human studies actually use?
Most published human NMN trials have used 250 to 600 mg per day. Safety studies have gone up to 1,200 mg with no serious adverse events reported. Starting at 250 to 500 mg puts you within the range where the majority of the human evidence sits.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Written by Dr. Lena Fischer, Nutritional Scientist.